Skip to content
Home/Companies/Healthcare / Biotech/Mission Therapeutics
Mission Therapeutics

Mission Therapeutics

Healthcare / Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Mission Therapeutics?

Mission Therapeutics is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021. Across its history, Mission Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Rosetta Capital
Most recent investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare / Biotech
Websitemissiontherapeutics.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners and Rosetta Capital since 2019.
Co-invest · 2 holders · 2019 · present
Sofinnova Partners
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Rosetta Capital
Rosetta CapitalActive
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries

More from Rosetta Capital V

Other portfolio companies in the same fund.

Carrick Therapeutics
Carrick Therapeutics
Active
BiotechIreland· 2021
Immunocore
Immunocore
Active
BiotechUK· 2021
Inivata
Inivata
Exited 2021
HealthTechUK· 2021
to
Mereo BioPharma
Mereo BioPharma
Active
BiotechUK· 2021
PsiOxus Therapeutics
Active
BiotechUK· 2021
ReNeuron
ReNeuron
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Mission Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Mission Therapeutics?

2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Mission Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue